Anti-emetics Flashcards
Chemotherapy induced nausea and vomiting pathophysiology
Cisplatin used for lung cancer chemotherapy (chemotherapy induced nausea and vomiting)
- Cisplatin toxic to enterochromaffin cells, leading to free radical release
- Free radicals stimulate excess serotonin release
- Serotonin activates 5-HT receptors on the nerve fibres to nucleus tractus solaris (NTS), nerve fibres to vomiting centre (VC) and nerve fibres to chemoreceptor trigger zone (CTZ)
- leads to vomiting reflex
Chemotherapy induced nausea and vomiting treatment
ONDANSTERON
-5-HT3A receptor antagonist to prevent vomiting side effect from chemotherapy
-oral administration and excreted in urine
-side effects include headache, flushing and constipation
GLUCOCORTICOIDS
-combination use to reduce free radical production
AREPEPRITANT
-neurokinin-1 receptor antagonist
Mechanistic vomiting triggers
1) Cytotoxic drugs
2) Motion sickness
3) Gastrointestinal problems
Motion sickness pathophysiology
- Neural mismatch between signals from auditory labyrinth (inner ear fluid responsible for balance) and vestibular system (via muscarinic receptors)
- increased hypothalamic histamine release leads to Histamine H1 receptor activation in chemoreceptor trigger zone (CTZ)
- vestibular system and hypothalamus also activate vomiting centre (VC) through cholinergic system
Motion sickness treatment
PROMETHAZINE
-Histamine H1 receptor antagonist
-acts centrally to block vomiting centre activation
-best used prophylactically
-oral administration
-1-2 hours before action onset
-24 hour action
-side effects include dizziness, tinnitus, fatigue, sedation, excitation (in excess) and convulsions
HYOSCINE (Scopolomine)
-Non-selective muscarinic receptor antagonist
-needs to be given prophylactically (little effect if given after onset)
-oral administration or via transdermal patch
-side effects include drowsniess, dry mouth, cycloplegia, mydriasis and constipation
Gastrointestinal
problem pathophysiology
Vomiting due to unknown cause
- Gastroparesis (delayed emptying of the stomach contents due to reduced stomach contraction and often accompanied with abdominal pain, bloating and feeling full quickly etc)
- causes serotonin release, leading to the activation of 5-HT receptors on nerve fibres to vomiting centre (VC) and nerve fibres to chemoreceptor trigger zone (CTZ)
Gastrointestinal problems vomiting treatment
METOCLOPRAMIDE
-Dual action as Dopamine D2 receptor antagonist and 5-HT3A receptor antagonist
Dopamine D2 receptor antagonist
- prokinetic, increasing smooth muscle motility and stimulating gastric emptying->accelerates transit of intestinal contents
- inhibits Dopamine D2 receptors in vomiting centre (VC)
5-HT3A receptor antagonist
- inhibition of chemoreceptor trigger zone (CTZ) activation
- side effects include drowsiness, dizziness, anxiety, extrapyramidal reactions (Parkinsonian-like syndrome), hyperprolactinaemia, galactorrhoea and menstruation disorders
Anti-emetic drug classes
- 5-HT3A receptor antagonists
- Histamine H1 receptor antagonists
- Muscarinic receptor antagonists
- Dopamine D2 receptor antagonists
Physiological control of nausea/vomiting
- Area postrema (vomiting centre)=innervated by nucleus of tractus solitarius
- Chemoreceptor trigger zone=communicates with vomiting centre